Arnold & Porter Guides Launch of Banyan Bio, a New Life Sciences Investment Firm
Arnold & Porter advised Banyan Bio on its launch, securing over $100 million in commitments. The firm will focus on clinical-stage drug assets, providing development support and strategic guidance.